Thermo Fisher Scientific Inc. (NYSE:TMO) was tapped to provide biorepository services for the National Children’s Study, which examines the effects of environmental influences on the health and development of 100,000 children in the U.S.
The Waltham, Mass.-based lab instruments maker’s Fisher BioServices division will provide storage for patient specimens and environmental samples for the study, which tracks the kids from before birth until age 21. The NCS, a joint effort by National Institutes of Health, the Centers for Disease Control and the Environmental Protection Agency, will look into the influence of environmental factors on children’s health.
Thermo Fisher president and CEO Marc Casper said the company is “honored” to be a part of the study, according to a press release. Fisher BioServices will create a biorepository to handle the organization, storing and disbursement of the samples to researchers.
